Your prediction
Braskem Pfd ADR Stock
There is an upward development for Braskem Pfd ADR compared to yesterday, with an increase of €0.040 (1.680%).
Pros and Cons of Braskem Pfd ADR in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Cons
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Braskem Pfd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Braskem Pfd ADR | 1.680% | 2.542% | -2.419% | -37.306% | -32.778% | -71.696% | -66.849% |
| Braskem Pfd A | -0.780% | 13.158% | 9.322% | -29.891% | -32.461% | -68.382% | -65.323% |
| Ingevity Corp | -0.790% | 4.775% | 22.981% | 27.344% | 30.723% | - | - |
| PTT Global Chemical -fgn- | 5.880% | 0.000% | 5.372% | -17.073% | -21.538% | -57.500% | -66.225% |
Comments
Braskem S.A. (NYSE: BAK) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Show more
Ratings data for BAK provided by MarketBeat
Braskem S.A. (NYSE: BAK) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Show more
Ratings data for BAK provided by MarketBeat
Braskem S.A. (NYSE: BAK) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating.
Show more
Ratings data for BAK provided by MarketBeat